Publications by authors named "Lothar Weissbach"

Claim this Profile
O
Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.
Charlie A Hamm, Patrick Asbach, Anna Pöhlmann, Ivo G Schoots, Veeru Kasivisvanathan

JAMA Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urologist communication is a primary factor leading to erectile dysfunction treatment postprostatectomy.
Martin Baunacke, Christer Groeben, Angelika Borkowetz, Falk Hoffmann, Felix K H Chun, Lothar Weissbach

J Sex Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of intermediate-risk prostate cancer with active surveillance in the routine care-Long-term outcomes of a prospective noninterventional study (HAROW).
Lothar Weissbach, Andreas Schwarte, Edith A Boedefeld, Jan Herden

Curr Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fifteen-year results of the ProtecT study-commentary].
Lothar Weißbach

Urologie· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gender-Sensitive Depression Screening (GSDS) - Further Validation of a New Self-Rating Instrument].
Anne Maria Möller-Leimkühler, Anja Jackl, Lothar Weissbach

Psychiatr Prax· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer.
Kristine Kreis, Dirk Horenkamp-Sonntag, Udo Schneider, Jan Zeidler, Gerd Glaeske, Lothar Weissbach

BJU Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Active surveillance-much safety, little recruitment : Is it possible to extend the indication for "intermediate-risk" prostate cancer?].
Lothar Weißbach, Edith A Boedefeld, Jan Herden

Urologe A· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.
Jan Herden, Andreas Schwarte, Edith A Boedefeld, Lothar Weissbach

Urol Int· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of post-prostatectomy urinary incontinence and erectile dysfunction: there is insufficient utilisation of care in German cancer survivors.
Martin Baunacke, Maria-Luisa Schmidt, Christer Groeben, Angelika Borkowetz, Christian Thomas, Lothar Weissbach

World J Urol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study.
Jan Herden, Andreas Schwarte, Thorsten Werner, Uwe Behrendt, Axel Heidenreich, Lothar Weissbach

World J Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study.
Kristine Kreis, Dirk Horenkamp-Sonntag, Udo Schneider, Jan Zeidler, Gerd Glaeske, Lothar Weissbach

Pharmacoecon Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[It is unclear whether pelvic lymphadenectomy is of oncological benefit in prostate cancer].
Lothar Weißbach, Christiane Roloff

Aktuelle Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term Followup.
Christian Gilfrich, Matthias May, Claus Fahlenbrach, Christian Günster, Elke Jeschke, Lothar Weissbach

J Urol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term functional outcomes after robotic vs. retropubic radical prostatectomy in routine care: a 6-year follow-up of a large German health services research study.
Martin Baunacke, Maria-Luisa Schmidt, Christian Thomas, Christer Groeben, Angelika Borkowetz, Lothar Weissbach

World J Urol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Noninvasive treatment of organ-confined prostate cancer in elderly patients-results of the HAROW study].
Jan Herden, Edith A Boedefeld, Lothar Weißbach

Urologe A· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision Regret after Radical Prostatectomy does Not Depend on Surgical Approach: 6-Year Followup of a Large German Cohort Undergoing Routine Care.
Martin Baunacke, Maria-Luisa Schmidt, Christer Groeben, Angelika Borkowetz, Christian Thomas, Lothar Weissbach

J Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Martin Baunacke, Maria-Luisa Schmidt, Christer Groeben, Angelika Borkowetz, Christian Thomas, Lothar Weissbach

J Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the Recommendation of a Pelvic Lymphadenectomy in Conjunction with Radical Prostatectomy in Prostate Cancer Patients Justified? Report from a Multidisciplinary Expert Panel Meeting.
Alexander Winter, Rolf Harzmann, Johann Jakob Wendler, Christiane Roloff, Steffen Weikert, Lothar Weissbach

Adv Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific health-related quality of life and patient-physician communication - A 3.5-year follow-up.
Nicole Ernstmann, Jan Herden, Lothar Weissbach, André Karger, Kira Hower

Patient Educ Couns· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancy between theory and practice of the clinical tumor-nodes-metastasis (TNM) classification for localized prostate cancer.
Jan Herden, Christian Wittekind, Lothar Weissbach

Ann Transl Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of the UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classification for patients treated with radical prostatectomy.
Jan Herden, Axel Heidenreich, Christian Wittekind, Lothar Weissbach

Cancer Epidemiol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Lena Ansmann, Nicola Winter, Nicole Ernstmann, Axel Heidenreich, Lothar Weissbach

BJU Int· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.
Friedemann Honecker, Ulrich Wedding, Gerd Kallischnigg, Axel Schroeder, Jörg Klier

J Cancer Res Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
Jan Herden, Lothar Weissbach

World J Urol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.
Alexander D J Baur, Thomas Henkel, Manfred Johannsen, Thomas Speck, Lothar Weißbach

Contemp Clin Trials· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis